Budesonide Use and Hospitalization Rate in Crohn’s Disease: Results From a Cohort at a Tertiary Care IBD Referral Center

BACKGROUND: Budesonide is generally not used for periods > 90 days in Crohn’s disease (CD). We sought to study the association between cumulative outpatient budesonide use in days and hospitalization rate in CD patients seen at our institution. METHODS: Using a retrospective cohort study design,...

Descripción completa

Detalles Bibliográficos
Autores principales: Orr, Jordan, Venkata, Krishna V. R., Young, Steven, Xie, Fenglong, Malik, Talha A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012238/
https://www.ncbi.nlm.nih.gov/pubmed/27635174
http://dx.doi.org/10.14740/jocmr2630w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012238/
https://www.ncbi.nlm.nih.gov/pubmed/27635174
http://dx.doi.org/10.14740/jocmr2630w

Ejemplares similares